450 Participants Needed

Implementation Support Strategies for Disruptive Behaviors

(SKIPforPA Trial)

Recruiting at 1 trial location
KM
SM
ON
SI
Overseen BySatish Iyengar, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Pittsburgh
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

In a prior application (MH064372), the investigators' treatment research program (Services for Kids In Primary-care, SKIP) developed and tested a chronic care model-based intervention, called Doctor Office Collaborative Care (DOCC), that was found to be effective in the management of childhood behavior problems and comorbid ADHD. In the "SKIP for PA Study", the investigators propose to conduct a randomized clinical trial to evaluate the effects of team- and practice leadership-level implementation strategies designed to enhance the use and uptake of DOCC in diverse pediatric primary care offices.

Will I have to stop taking my current medications?

The trial information does not specify whether participants need to stop taking their current medications.

What data supports the effectiveness of the treatment DOCC for disruptive behavior and ADHD?

Research shows that the Doctor Office Collaborative Care (DOCC) model is effective for managing behavior problems and ADHD in children, as it has been demonstrated to improve outcomes compared to usual care. Additionally, it may help reduce mental health care costs for children.12345

Is the Doctor Office Collaborative Care (DOCC) model safe for treating disruptive behaviors in children?

The available research does not specifically address the safety of the DOCC model, but it is a collaborative care approach used in primary care settings, which generally suggests it is considered safe for managing pediatric behavior problems and ADHD.13567

How is the DOCC treatment for disruptive behavior and ADHD different from other treatments?

The DOCC treatment is unique because it involves a collaborative care approach where healthcare providers work closely with families and schools to manage disruptive behaviors and ADHD, focusing on real-world implementation and engagement strategies to overcome practical barriers like scheduling and transportation.89101112

Research Team

DJ

David J Kolko, PhD

Principal Investigator

University of Pittsburgh

Eligibility Criteria

This trial is for caregivers with a child aged 5-12 showing behavior problems, and staff at selected pediatric practices in PA. Staff roles include primary care providers, care managers, medical directors/senior leaders, and practice managers.

Inclusion Criteria

SL Participants: Employed at one of the up to twenty-four (24) pediatric primary care practices identified by the PA Medical Home Program at the PA AAP or by the University of Pittsburgh research team. Identified by the practice as the Senior Leader. Have a practice-level leadership role such as Medical Director or a clinical/practice leader. Have administrative responsibilities related to patient care and/or the operations/management of the practice.
I am a Practice Manager at a pediatric care practice selected for the study.
PCP Participants: Employed at one of the up to twenty-four (24) pediatric primary care practices identified by the PA Medical Home Program at the PA AAP or by the University of Pittsburgh research team. Identified by the practice as a Primary Care Provider
See 2 more

Exclusion Criteria

Caregivers: Already enrolled in the study as the caregiver to a different child (e.g., sibling)

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Training

Standard training in the DOCC evidence-based practice (EBP) for all practices

4 weeks

Implementation

Implementation of DOCC with various support strategies (TEAM, LEAD, or both) delivered via videoconference

24 months
Regular videoconference sessions

Follow-up

Participants are monitored for safety and effectiveness after treatment

6 months

Treatment Details

Interventions

  • DOCC: Evidence-based treatment for disruptive behavior and ADHD
  • Implementation support strategies at the leadership level following standard implementation of DOCC
  • TEAM: Implementation support strategies at the care team level following standard implementation of DOCC
Trial OverviewThe study tests if extra support strategies for teams and leadership can improve the use of DOCC—an effective treatment program for childhood behavior issues and ADHD—in various pediatric offices.
Participant Groups
4Treatment groups
Experimental Treatment
Active Control
Group I: DOCC with TEAM implementationExperimental Treatment2 Interventions
Practices in this arm will receive DOCC training and materials and one type of implementation support after the training: coaching/consultation for the provider care team (TEAM).
Group II: DOCC with TEAM + LEAD implementationExperimental Treatment3 Interventions
Practices in this arm will receive DOCC training and materials and both types of implementation support after the training: coaching/consultation for the provider care team (TEAM) and facilitation for practice leadership (LEAD).
Group III: DOCC with LEAD implementationExperimental Treatment2 Interventions
Practices in this arm will receive DOCC training and materials and only one type of implementation support after the training: facilitation for practice leadership (LEAD).
Group IV: DOCC with standard implementation (No TEAM or LEAD)Active Control1 Intervention
Practices in this arm will receive DOCC materials/training and technical support, but will not receive care team coaching/consultation (TEAM) or practice leadership facilitation (LEAD) after the training phase.

DOCC: Evidence-based treatment for disruptive behavior and ADHD is already approved in United States for the following indications:

🇺🇸
Approved in United States as DOCC for:
  • Disruptive behavior
  • Attention-deficit/hyperactivity disorder (ADHD)

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Pittsburgh

Lead Sponsor

Trials
1,820
Recruited
16,360,000+

Pennsylvania American Academy of Pediatrics

Collaborator

Trials
2
Recruited
480+

NYU Langone Health

Collaborator

Trials
1,431
Recruited
838,000+

University of Michigan

Collaborator

Trials
1,891
Recruited
6,458,000+

Pennsylvania Chapter American Academy of Pediatrics

Collaborator

Trials
1
Recruited
450+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

American Academy of Pediatrics

Collaborator

Trials
46
Recruited
4,071,000+

Drexel University

Collaborator

Trials
160
Recruited
48,600+

Findings from Research

The Doctor Office Collaborative Care (DOCC) model significantly improved treatment initiation and completion rates for children with behavior problems, ADHD, and anxiety, with 99.4% starting treatment compared to 54.2% in enhanced usual care (EUC).
DOCC also led to notable improvements in behavior issues, parental stress, and overall family satisfaction, demonstrating its effectiveness in pediatric primary care settings over a 6-month intervention period.
Collaborative care outcomes for pediatric behavioral health problems: a cluster randomized trial.Kolko, DJ., Campo, J., Kilbourne, AM., et al.[2022]
A new web-based training platform for school clinicians was developed to enhance their skills in evidence-based practices for treating youth with ADHD, showing high usability and clinician satisfaction.
The outcomes for students trained by clinicians using this remote platform were comparable to those achieved through traditional in-person training, indicating that online training can effectively disseminate evidence-based practices.
Development of a Web-Based Training Platform for School Clinicians in Evidence-Based Practices for ADHD.Pfiffner, LJ., Dvorsky, MR., Friedman, LM., et al.[2023]
The doctor-office collaborative care (DOCC) model was found to be effective for treating pediatric behavior problems and ADHD, showing improved clinical outcomes compared to enhanced usual care (EUC) in a randomized controlled trial with 321 child participants over a 6-month period.
While the DOCC model had higher initial intervention costs, it resulted in lower overall costs for community mental health services during and shortly after the intervention, suggesting potential cost savings alongside improved treatment effectiveness.
Collaborative mental health care for pediatric behavior disorders in primary care: Does it reduce mental health care costs?Yu, H., Kolko, DJ., Torres, E.[2018]

References

Collaborative care outcomes for pediatric behavioral health problems: a cluster randomized trial. [2022]
Development of a Web-Based Training Platform for School Clinicians in Evidence-Based Practices for ADHD. [2023]
Collaborative mental health care for pediatric behavior disorders in primary care: Does it reduce mental health care costs? [2018]
Doctor-office collaborative care for pediatric behavioral problems: a preliminary clinical trial. [2023]
Targeted child psychiatric services: a new model of pediatric primary clinician--child psychiatry collaborative care. [2018]
Treatment of aggressive ADHD in children and adolescents: conceptualization and treatment of comorbid behavior disorders. [2015]
Follow-up care of children identified with ADHD by primary care clinicians: A prospective cohort study. [2018]
A Systematic Review and Evaluation of Clinical Practice Guidelines for Children and Youth with Disruptive Behavior: Rigor of Development and Recommendations for Use. [2020]
Case Management as a Significant Component of Usual Care Psychotherapy for Youth with Disruptive Behavior Problems. [2021]
Testing the 4Rs and 2Ss Multiple Family Group intervention: study protocol for a randomized controlled trial. [2019]
11.United Statespubmed.ncbi.nlm.nih.gov
Stakeholder-Generated Implementation Strategies to Promote Evidence-Based ADHD Treatment in Community Mental Health. [2022]
12.United Statespubmed.ncbi.nlm.nih.gov
Clinician-Identified Factors in Success of Parent-Directed Behavioral Therapy for Children's Tantrums. [2022]